US · Healthcare

Avidity Biosciences Inc (RNA)

Biotechnology

Avidity Biosciences Inc (RNA) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for RNA

P/E ratio

25.00

Avidity Biosciences Inc (RNA) — FAQ

What is RNA's P/E ratio?

The price-to-earnings (P/E) ratio for Avidity Biosciences Inc (RNA) is 25.00 (data as of 2026-05-24).

Does Avidity Biosciences Inc pay a dividend?

Dividend yield is not available in the current snapshot for Avidity Biosciences Inc (RNA). Check the MyAverix Finance app for the latest dividend data.

What sector is Avidity Biosciences Inc in?

Avidity Biosciences Inc (RNA) is classified in the Healthcare sector (Biotechnology industry).

What exchange is RNA listed on?

RNA is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)